PMID- 34099588 OWN - NLM STAT- MEDLINE DCOM- 20211209 LR - 20211214 IS - 1899-1505 (Electronic) IS - 0867-5910 (Linking) VI - 72 IP - 1 DP - 2021 Feb TI - Altered serum levels of autophagy proteins Beclin-1 and mTOR in patients with exudative age-related macular degeneration. LID - 10.26402/jpp.2021.1.09 [doi] AB - Autophagy is a key process in the maintenance of cellular survival and homeostasis. Inhibition of autophagy results in degenerative changes resembling ageing. We wondered if autophagy can contribute to the pathogenesis of age-related macular degeneration (AMD). We aimed to investigate the serum concentrations of two key autophagy regulators, Beclin-1 and mechanistic target of rapamycin (mTOR), in patients with exudative AMD. This retrospective case-control study included 38 patients with exudative AMD and 36 sex- and age-matched controls selected among senile cataract patients. Circulating Beclin-1 and mTOR were assessed using an enzyme-linked immunosorbent assay. The proteins levels were correlated with age, sex, duration of ocular symptoms, as well as angiographic and optical coherence tomography findings. Serum Beclin-1 levels were much lower in patients with AMD than in controls (median, 0.100 ng/ml versus 1.123 ng/ml; p = 0.0033), while mTOR levels did not differ (median, 4.377 ng/ml versus 3.608 ng/ml; p = 0.4522). Participants of the study older than 70 years had lower Beclin-1 levels than younger ones (p = 0.0444). However, this difference was the most evident in patients with AMD (p = 0.0024). Serum mTOR levels increased with age. In patients with AMD, lower mTOR levels were associated with drusen, while higher levels were observed in those with a fibrous scar in the contralateral eye (p = 0.0212). Our findings suggest that circulating Beclin-1 decreases with age and that is downregulated in patients with AMD. FAU - Kubicka-Trzaska, A AU - Kubicka-Trzaska A AD - Jagiellonian University Medical College, Faculty of Medicine, Chair of Ophthalmology, Cracow, Poland. agnieszka.kubicka-trzaska@uj.edu.pl. FAU - Zuber-Laskawiec, K AU - Zuber-Laskawiec K AD - Jagiellonian University Medical College, Faculty of Medicine, Chair of Ophthalmology, Cracow, Poland. FAU - Plutecka, H AU - Plutecka H AD - Jagiellonian University Medical College, Faculty of Medicine, Division of Molecular Biology and Clinical Genetics, Cracow, Poland. FAU - Romanowska-Dixon, B AU - Romanowska-Dixon B AD - Jagiellonian University Medical College, Faculty of Medicine, Chair of Ophthalmology, Cracow, Poland. FAU - Sanak, M AU - Sanak M AD - Jagiellonian University Medical College, Faculty of Medicine, Division of Molecular Biology and Clinical Genetics, Cracow, Poland. FAU - Karska-Basta, I AU - Karska-Basta I AD - Jagiellonian University Medical College, Faculty of Medicine, Chair of Ophthalmology, Cracow, Poland. LA - eng PT - Journal Article DEP - 20210221 PL - Poland TA - J Physiol Pharmacol JT - Journal of physiology and pharmacology : an official journal of the Polish Physiological Society JID - 9114501 RN - 0 (BECN1 protein, human) RN - 0 (Beclin-1) RN - EC 2.7.1.1 (MTOR protein, human) RN - EC 2.7.11.1 (TOR Serine-Threonine Kinases) SB - IM MH - Age Factors MH - Aged MH - Aged, 80 and over MH - Autophagy/*physiology MH - Beclin-1/*blood MH - Case-Control Studies MH - Female MH - Fluorescein Angiography MH - Humans MH - Male MH - Middle Aged MH - Retrospective Studies MH - TOR Serine-Threonine Kinases/*blood MH - Tomography, Optical Coherence MH - Wet Macular Degeneration/blood/*physiopathology EDAT- 2021/06/09 06:00 MHDA- 2021/12/15 06:00 CRDT- 2021/06/08 05:58 PHST- 2021/01/29 00:00 [received] PHST- 2021/02/26 00:00 [accepted] PHST- 2021/06/08 05:58 [entrez] PHST- 2021/06/09 06:00 [pubmed] PHST- 2021/12/15 06:00 [medline] AID - 10.26402/jpp.2021.1.09 [doi] PST - ppublish SO - J Physiol Pharmacol. 2021 Feb;72(1). doi: 10.26402/jpp.2021.1.09. Epub 2021 Feb 21.